← Back to Clinical Trials
Recruiting NCT06642246

NCT06642246 Sleep Promotion and Pediatric Hypertension

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06642246
Status Recruiting
Phase
Sponsor Children's Hospital of Philadelphia
Condition Insufficient Sleep
Study Type INTERVENTIONAL
Enrollment 10 participants
Start Date 2026-02-16
Primary Completion 2026-06

Trial Parameters

Condition Insufficient Sleep
Sponsor Children's Hospital of Philadelphia
Study Type INTERVENTIONAL
Phase N/A
Enrollment 10
Sex ALL
Min Age 13 Years
Max Age 18 Years
Start Date 2026-02-16
Completion 2026-06
Interventions
Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Determine the effectiveness and feasibility of a mobile health sleep extension approach in the pediatric nephrology setting, to increase sleep duration and reduce systolic and diastolic blood pressure.

Eligibility Criteria

Inclusion Criteria: * Speak, read and write in English. * Parental/guardian permission (informed consent) and child assent. * Have a computer or a tablet computer with access to the Internet or own a smartphone with a data and text plan. * Parent reported sleep duration on school nights less than or equal to 7.5 hours. * Recently diagnosed with essential hypertension by Ambulatory Blood Pressure Monitoring (ABPM). * If taking over the counter sleep aides, willing to stop them over the course of the study. Exclusion Criteria: * Any clinically diagnosed sleep disorder (e.g. sleep apnea) in the electronic health record and or regular use of prescribed sleep aide. * Underlying chronic medical conditions, defined as a medical condition with a duration or expected duration longer than 3 months that involved taking regular medication, taking medications that could affect blood pressure (e.g., anti-hypertensive medications, glucocorticoids, or stimulants), and patients with underlying diagnose

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology